A novel mutation identified in carnitine palmitoyltransferase II deficiency

被引:26
|
作者
Yang, BZ
Ding, JH
Roe, D
Dewese, T
Day, DW
Roe, CR
机构
[1] Baylor Univ, Med Ctr, Inst Metab Dis, Dallas, TX 75226 USA
[2] Columbia Childrens Hosp Med City, Dallas, TX USA
关键词
D O I
10.1006/mgme.1997.2656
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Carnitine palmitoyltransferase II (CPT II) deficiency is an autosomal recessive disorder of mitochondrial fatty-acid oxidation which presents as three distinct phenotypes (neonatal, infantile, and adult onset). CPT II exons from an adult-onset CPT II-deficient patient were amplified and directly sequenced to further investigate the molecular basis of this disorder. A novel mutation, C471T, in exon 4 of the carnitine palmitoyltransferase II gene was found which created a stop codon, TGA, at residue 124 of the protein (R124Stop). This mutation would result in severe protein truncation. This unique mutation was found on one allele while the S113L mutation, previously reported, was present on the other allele. (C) 1998 Academic Press.
引用
收藏
页码:110 / 115
页数:6
相关论文
共 50 条
  • [1] A Case of Carnitine Palmitoyltransferase II Deficiency in Bahrain With a Novel Mutation
    Alsahlawi, Zahra
    Fadhul, Zainab
    Mahmood, Ali
    Mohamed, Ali
    Khalil, Mohamed
    Aljishi, Emtithal
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2022, 14 (06)
  • [2] Identification of a novel mutation in patient with carnitine palmitoyltransferase II (CPT II) deficiency.
    Yang, BZ
    Zhang, LF
    Roe, DS
    Roe, CR
    Wiltse, HE
    Ding, JH
    AMERICAN JOURNAL OF HUMAN GENETICS, 2000, 67 (04) : 290 - 290
  • [3] CAUSE OF RECURRENT RHABDOMYOLYSIS, CARNITINE PALMITOYLTRANSFERASE II DEFICIENCY AND NOVEL PATHOGENIC MUTATION
    Cakar, Nafiye Emel
    Gor, Zeynep
    Yesil, Gozde
    IDEGGYOGYASZATI SZEMLE-CLINICAL NEUROSCIENCE, 2021, 74 (3-4): : 135 - 138
  • [4] Splice junction mutation in muscle carnitine palmitoyltransferase II deficiency
    Deschauer, M
    Chrzanowska-Lightowlers, ZMA
    Biekmann, E
    Pourfarzam, M
    Taylor, RW
    Turnbull, DM
    Zierz, S
    MOLECULAR GENETICS AND METABOLISM, 2003, 79 (02) : 124 - 128
  • [5] Novel mutations associated with carnitine palmitoyltransferase II deficiency
    Taggart, RT
    Smail, D
    Apolito, C
    Vladutiu, GD
    HUMAN MUTATION, 1999, 13 (03) : 210 - 220
  • [6] Mutation and biochemical analysis in carnitine palmitoyltransferase type II (CPT II) deficiency
    Olpin, SE
    Afifi, A
    Clark, S
    Manning, NJ
    Bonham, JR
    Dalton, A
    Leonard, JV
    Land, JM
    Andresen, BS
    Morris, AA
    Muntoni, F
    Turnbull, D
    Pourfarzam, M
    Rahman, S
    Pollitt, RJ
    JOURNAL OF INHERITED METABOLIC DISEASE, 2003, 26 (06) : 543 - 557
  • [7] A novel nonsense mutation (515del4) in muscle carnitine palmitoyltransferase II deficiency
    Deschauer, M
    Wieser, T
    Schröder, R
    Zierz, S
    MOLECULAR GENETICS AND METABOLISM, 2002, 75 (02) : 181 - 185
  • [8] Statin use in carnitine palmitoyltransferase II deficiency
    Saeed, Anum
    Hadley, Trevor D.
    Jia, Xiaoming
    Ballantyne, Christie M.
    JOURNAL OF CLINICAL LIPIDOLOGY, 2019, 13 (04) : 550 - 553
  • [9] Myopathy in the course of carnitine palmitoyltransferase II deficiency
    Durka-Kesy, Marta
    Stepien, Adam
    Tomczykiewicz, Kazimierz
    Fidzianska, Anna
    Niebroj-Dobosz, Irena
    Pastuszak, Zanna
    NEUROLOGIA I NEUROCHIRURGIA POLSKA, 2012, 46 (06) : 600 - 602
  • [10] Muscular carnitine palmitoyltransferase II deficiency in infancy
    Hurvitz, H
    Klar, A
    Korn-Lubetzki, I
    Wanders, RJA
    Elpeleg, ON
    PEDIATRIC NEUROLOGY, 2000, 22 (02) : 148 - 150